160 related articles for article (PubMed ID: 32712951)
1. Another set of guidelines for chronic myeloid leukaemia.
Clark RE
Br J Haematol; 2020 Oct; 191(2):147-149. PubMed ID: 32712951
[No Abstract] [Full Text] [Related]
2. The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia.
Gallipoli P; Clark RE; Byrne J; Apperley JF; Milojkovic D; Foroni L; Goldman JM; O'Brien S
Br J Haematol; 2022 Mar; 196(6):e55-e57. PubMed ID: 34993961
[No Abstract] [Full Text] [Related]
3. Managing children with chronic myeloid leukaemia.
Baccarani M
Br J Haematol; 2015 Jun; 169(5):759-60. PubMed ID: 25430625
[No Abstract] [Full Text] [Related]
4. Concomitant diagnosis of chronic myeloid leukaemia and myeloma.
Looi W; Zargari A; Dun K; Grigoriadis G; Fedele P; Gregory GP; Low MSY
Pathology; 2022 Jun; 54(4):493-495. PubMed ID: 34776244
[No Abstract] [Full Text] [Related]
5. Managing children with chronic myeloid leukaemia--response to Baccarani.
Millot F; Suttorp M
Br J Haematol; 2015 Jun; 169(5):760-1. PubMed ID: 25573033
[No Abstract] [Full Text] [Related]
6. Chronic spontaneous urticaria as the presenting feature in a paediatric case of chronic myeloid leukaemia.
Sutton KM; Wiggins M; Zaragoza R; Swamy S
Pediatr Blood Cancer; 2024 Mar; 71(3):e30846. PubMed ID: 38185755
[No Abstract] [Full Text] [Related]
7. Chronic myeloid leukaemia. I. Some observations on chronic myeloid leukaemia.
GALTON DA
Br J Radiol; 1953 Jun; 26(306):285-90. PubMed ID: 13051542
[No Abstract] [Full Text] [Related]
8. Chronic myeloid leukaemia presenting with bilateral papilloedema.
Keh YS; Mathur S; Naqvi S; Shaunak S
Br J Hosp Med (Lond); 2021 Jan; 82(1):1. PubMed ID: 33512295
[No Abstract] [Full Text] [Related]
9. How to individualize therapy after failing milestones in chronic myeloid leukaemia: weighting late response and early death from CML against risk of alternative therapies.
Hehlmann R; Lauseker M
Leukemia; 2024 Feb; 38(2):465-466. PubMed ID: 38218735
[No Abstract] [Full Text] [Related]
10. Acute abdomen in a patient with chronic myeloid leukaemia.
Voppuru SR; Patkar S
Indian J Med Res; 2020 Nov; 152(Suppl 1):S134-S135. PubMed ID: 35345168
[No Abstract] [Full Text] [Related]
11. BCR-ABL1 mutation screening in chronic myeloid leukaemia: is next now?
Soverini S; Martelli M; Bavaro L
Lancet Haematol; 2019 May; 6(5):e236-e237. PubMed ID: 31036315
[No Abstract] [Full Text] [Related]
12. Histamine and histaminase in chronic myeloid leukaemia of man: histamine in the blood of chronic myeloid leukaemia.
THIERSCH JB
Aust J Exp Biol Med Sci; 1947 Mar; 25():73-7. PubMed ID: 20266429
[No Abstract] [Full Text] [Related]
13. STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia.
O'Dwyer ME; Druker BJ
Lancet Oncol; 2000 Dec; 1():207-11. PubMed ID: 11905636
[TBL] [Abstract][Full Text] [Related]
14. Do not forget megakaryocytes morphology when you deal with chronic myeloid leukaemia.
Rieu JB; Tavitian S; Vergez F; Largeaud L
Ann Biol Clin (Paris); 2020 Dec; 78(6):691-692. PubMed ID: 33079062
[No Abstract] [Full Text] [Related]
15. Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia.
Hughes T; Branford S
Blood Rev; 2006 Jan; 20(1):29-41. PubMed ID: 16426942
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of leukaemia. I. Myleran in the treatment of chronic myeloid leukaemia.
GREIG HB
S Afr Med J; 1956 Apr; 30(15):357-60. PubMed ID: 13324391
[No Abstract] [Full Text] [Related]
17. Chronic lymphocytic leukaemia developing in the course of chronic myeloid leukaemia.
Salim R; Wang L; Lin K; Clark RE
Leuk Lymphoma; 2002 Nov; 43(11):2225-7. PubMed ID: 12533052
[TBL] [Abstract][Full Text] [Related]
18. Time for patient reported outcomes assessment in routine hematology practice: the case of chronic myeloid leukemia.
Efficace F; Cottone F
Expert Rev Hematol; 2019 Jan; 12(1):1-3. PubMed ID: 30411646
[No Abstract] [Full Text] [Related]
19. Chronic myeloid leukaemia: A qualitative interview study exploring disease impact from patient and practitioner perspectives.
Hewison A; Roman E; Smith A; McCaughan D; Sheridan R; Patmore R; Atkin K; Howell D
Eur J Oncol Nurs; 2023 Dec; 67():102421. PubMed ID: 37804754
[TBL] [Abstract][Full Text] [Related]
20. Late-onset marrow aplasia due to imatinib in newly diagnosed chronic phase chronic myeloid leukaemia.
Chng WJ; Tan LH
Leuk Res; 2005 Jun; 29(6):719-20. PubMed ID: 15863215
[No Abstract] [Full Text] [Related]
[Next] [New Search]
